Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 5Malignant Solid Neoplasm 2Stomach Neoplasms 1Solid Tumors 1Solid Tumor 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Rectal Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Mesothelioma, Malignant 1Malignant Female Reproductive System Neoplasm 1Liposarcoma 1Fallopian Tube Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Childhood Central Nervous System Choriocarcinoma 1Anatomic Stage III Breast Cancer AJCC v8 1Advanced Solid Tumor 1Advanced Malignant Solid Neoplasm 1

Interventions

pembrolizumab 14Injections 13Paclitaxel 10Nivolumab 10Docetaxel 9Cisplatin 9Capecitabine 9Bevacizumab 8toripalimab 7senaparib 7Fluorodeoxyglucose F18 7Cyclophosphamide 7tislelizumab 6atezolizumab 6Irinotecan 6Fluorouracil 6Gemcitabine 5fludarabine 4apatinib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4Carboplatin 4spartalizumab 3sintilimab 3pertuzumab 3olaparib 3camrelizumab 3Rifampin 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor × Magnetic Resonance Spectroscopy × Other solid neoplasm × Clear all
NCT05989997 2025-09-16

Phase I Clinical Trial of 68Ga-NOTA-SNA002

SmartNuclide Biopharma

Phase 1 Completed
17 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡